JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.56B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 3 |
AbbVie
ABBV
|
+$964M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
+$801M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$756M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.34B |
| 2 |
Amazon
AMZN
|
+$1.76B |
| 3 |
Cigna
CI
|
+$1.06B |
| 4 |
Morgan Stanley
MS
|
+$1.05B |
| 5 |
Microsoft
MSFT
|
+$1.05B |
Sector Composition
| 1 | Technology | 16.69% |
| 2 | Financials | 11.81% |
| 3 | Healthcare | 10.26% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
W&T Offshore
WTI
$263M
| $901K | ﹤0.01% |
242,105
-371,117
| -61% | -$1.38M |
|
|
ONCY
3502
Oncolytics Biotech
ONCY
$126M
| $900K | ﹤0.01% |
147,473
-3,200
| -2% | -$19.5K |
|
3503
Zymeworks
ZYME
$1.22B
| $900K | ﹤0.01% |
30,979
+30,844
| +22,847% | +$896K |
|
3504
Gladstone Capital
GLAD
$516M
| $898K | ﹤0.01% |
39,750
-3,600
| -8% | -$81.3K |
|
|
CFB
3505
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $896K | ﹤0.01% |
68,954
-36,508
| -35% | -$474K |
|
3506
Artivion
AORT
$1.87B
| $893K | ﹤0.01% |
40,058
-52,771
| -57% | -$1.18M |
|
3507
MidWestOne Financial Group
MOFG
$590M
| $889K | ﹤0.01% |
29,476
-16,613
| -36% | -$501K |
|
3508
Parsons
PSN
$8.13B
| $889K | ﹤0.01% |
26,367
+8,977
| +52% | +$303K |
|
3509
Avita Medical
RCEL
$163M
| $889K | ﹤0.01% |
50,128
+40,962
| +447% | +$726K |
|
|
SRT
3510
DELISTED
Startek Inc.
SRT
| $887K | ﹤0.01% |
160,809
-41,668
| -21% | -$230K |
|
3511
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$845M
| $883K | ﹤0.01% |
22,660
| – | – |
|
|
TSC
3512
DELISTED
TriState Capital Holdings, Inc.
TSC
| $881K | ﹤0.01% |
41,682
-1,936
| -4% | -$40.9K |
|
3513
Canadian Solar
CSIQ
$789M
| $879K | ﹤0.01% |
25,445
-298,838
| -92% | -$10.3M |
|
3514
IES Holdings
IESC
$7.2B
| $879K | ﹤0.01% |
19,236
+3,929
| +26% | +$180K |
|
3515
Athira Pharma
ATHA
$14.8M
| $877K | ﹤0.01% |
93,495
+81,104
| +655% | +$761K |
|
3516
Cosan
CSAN
$2.64B
| $876K | ﹤0.01% |
52,257
-21,042
| -29% | -$353K |
|
3517
Axsome Therapeutics
AXSM
$5.73B
| $871K | ﹤0.01% |
26,463
+1,250
| +5% | +$41.1K |
|
|
CERE
3518
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $868K | ﹤0.01% |
29,394
+5,595
| +24% | +$165K |
|
|
BCOV
3519
DELISTED
Brightcove, Inc.
BCOV
| $867K | ﹤0.01% |
75,182
-19,251
| -20% | -$222K |
|
|
FINMU
3520
DELISTED
Marlin Technology Corporation Unit
FINMU
| $867K | ﹤0.01% |
86,735
+35,566
| +70% | +$356K |
|
3521
Willdan Group
WLDN
$1.46B
| $865K | ﹤0.01% |
24,314
-30,400
| -56% | -$1.08M |
|
3522
Vanguard Intermediate-Term Treasury ETF
VGIT
$33.2B
| $862K | ﹤0.01% |
12,760
-3,558
| -22% | -$240K |
|
3523
Bolt Biotherapeutics
BOLT
$9.83M
| $861K | ﹤0.01% |
3,404
-801
| -19% | -$203K |
|
|
CSPR
3524
DELISTED
Casper Sleep Inc.
CSPR
| $859K | ﹤0.01% |
201,021
+35,029
| +21% | +$150K |
|
|
DAO
3525
Youdao
DAO
$1.05B
| $858K | ﹤0.01% |
71,001
-67,782
| -49% | -$819K |
|